Occlusive venopathy phenotype in hereditary pulmonary arterial hypertension

Arq Bras Cardiol. 2011 Jul;97(1):e8-10. doi: 10.1590/s0066-782x2011000900019.
[Article in English, Portuguese, Spanish]

Abstract

A 33-year-old male with severe hereditary pulmonary arterial hypertension had a confirmed diagnosis of occlusive venopathy and microvasculopathy. He remained stable for three and a half years on oral sildenafil, 75 mg t.i.d. (six-minute walked distance of 375 m vs 105 m at baseline), but required addition of bosentan (125 mg b.i.d.), subsequently. Despite the fatal outcome at five years post-diagnosis, the observations suggest a potential usefulness of vasodilators as a bridge for lung transplant in selected cases with significant venous/capillary involvement. The occurrence of veno-occlusive and capillary lesions in the familial form of pulmonary arterial hypertension reinforces the difficulties with the current classification of the disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Familial Primary Pulmonary Hypertension
  • Fatal Outcome
  • Humans
  • Hypertension, Pulmonary / drug therapy
  • Hypertension, Pulmonary / genetics
  • Hypertension, Pulmonary / pathology*
  • Lung / pathology*
  • Male
  • Phenotype
  • Piperazines / administration & dosage
  • Pulmonary Veno-Occlusive Disease / pathology*
  • Purines / administration & dosage
  • Sildenafil Citrate
  • Sulfones / administration & dosage
  • Vasodilator Agents / administration & dosage

Substances

  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate